Literature DB >> 27084067

Mutation analysis of the MS4A and TREM gene clusters in a case-control Alzheimer's disease data set.

Mahdi Ghani1, Christine Sato1, Erfan Ghani Kakhki1, J Raphael Gibbs2, Bryan Traynor3, Peter St George-Hyslop4, Ekaterina Rogaeva5.   

Abstract

Genome wide association studies have identified an association between Alzheimer's disease (AD) and common polymorphisms in the MS4A and TREM loci (each containing a cluster of homologous genes) and should be thoroughly investigated for the presence of potentially functional variations. We conducted a mutation analysis by next generation sequencing of 15 genes within the MS4A and TREM gene clusters; and catalogued rare coding variants detected in a North American data set of 210 cases and 233 controls. Investigation of the 5 homologues genes in the TREM locus revealed potentially damaging rare variants in TREM2, TREML1, TREML2, and TREML4. In agreement with a previous report, we observed a significant enrichment of TREM2-damaging missense substitutions in cases (N = 9; 4.2%) compared with controls (N=2; 0.9%; p = 0.010; after Yates' correction p = 0.022). Among known AD-associated TREM2 substitutions, we detected p.R47H, p.D87N, and p.H157Y affecting both TREM2 isoforms (NM_018965 and NM_001271821). In addition, we identified 2 cases with novel TREM2 variants (p.L205P and p.G219C), which mapped only to the isoform NM_001271821 at the C-terminus. Investigation of the MS4A gene cluster revealed that potentially damaging missense substitutions and loss-of-function variants were twice as frequent in controls (N = 19; 8.2%) than cases (N = 9; 4.3%), generating a nominally significant result (p = 0.047; after Yates' correction p = 0.07). Validation of our observation in large data sets might address the question whether such variants could contribute to the protective effect of the minor alleles of Genome wide association study-significant single nucleotide polymorphisms at the MS4A locus.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; MS4A6A; Mutation; TREM2; TREML2; Targeted sequencing

Mesh:

Substances:

Year:  2016        PMID: 27084067      PMCID: PMC8985522          DOI: 10.1016/j.neurobiolaging.2016.03.009

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  36 in total

1.  PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels.

Authors:  Yongwook Choi; Agnes P Chan
Journal:  Bioinformatics       Date:  2015-04-06       Impact factor: 6.937

2.  A mutation in APP protects against Alzheimer's disease and age-related cognitive decline.

Authors:  Thorlakur Jonsson; Jasvinder K Atwal; Stacy Steinberg; Jon Snaedal; Palmi V Jonsson; Sigurbjorn Bjornsson; Hreinn Stefansson; Patrick Sulem; Daniel Gudbjartsson; Janice Maloney; Kwame Hoyte; Amy Gustafson; Yichin Liu; Yanmei Lu; Tushar Bhangale; Robert R Graham; Johanna Huttenlocher; Gyda Bjornsdottir; Ole A Andreassen; Erik G Jönsson; Aarno Palotie; Timothy W Behrens; Olafur T Magnusson; Augustine Kong; Unnur Thorsteinsdottir; Ryan J Watts; Kari Stefansson
Journal:  Nature       Date:  2012-08-02       Impact factor: 49.962

3.  Identification of a CD20-, FcepsilonRIbeta-, and HTm4-related gene family: sixteen new MS4A family members expressed in human and mouse.

Authors:  Y Liang; T F Tedder
Journal:  Genomics       Date:  2001-03-01       Impact factor: 5.736

4.  R47H Variant of TREM2 Associated With Alzheimer Disease in a Large Late-Onset Family: Clinical, Genetic, and Neuropathological Study.

Authors:  Olena Korvatska; James B Leverenz; Suman Jayadev; Pamela McMillan; Irina Kurtz; Xindi Guo; Malia Rumbaugh; Mark Matsushita; Santhosh Girirajan; Michael O Dorschner; Kostantin Kiianitsa; Chang-En Yu; Zoran Brkanac; Gwenn A Garden; Wendy H Raskind; Thomas D Bird
Journal:  JAMA Neurol       Date:  2015-08       Impact factor: 18.302

5.  Genome-wide association study of exercise behavior in Dutch and American adults.

Authors:  Marleen H M De Moor; Yong-Jun Liu; Dorret I Boomsma; Jian Li; James J Hamilton; Jouke-Jan Hottenga; Shawn Levy; Xiao-Gang Liu; Yu-Fang Pei; Danielle Posthuma; Robert R Recker; Patrick F Sullivan; Liang Wang; Gonneke Willemsen; Han Yan; Eco J C De Geus; Hong-Wen Deng
Journal:  Med Sci Sports Exerc       Date:  2009-10       Impact factor: 5.411

6.  DAP12 Stabilizes the C-terminal Fragment of the Triggering Receptor Expressed on Myeloid Cells-2 (TREM2) and Protects against LPS-induced Pro-inflammatory Response.

Authors:  Li Zhong; Xiao-Fen Chen; Zhen-Lian Zhang; Zhe Wang; Xin-Zhen Shi; Kai Xu; Yun-Wu Zhang; Huaxi Xu; Guojun Bu
Journal:  J Biol Chem       Date:  2015-05-08       Impact factor: 5.157

7.  TREM2 variants in Alzheimer's disease.

Authors:  Rita Guerreiro; Aleksandra Wojtas; Jose Bras; Minerva Carrasquillo; Ekaterina Rogaeva; Elisa Majounie; Carlos Cruchaga; Celeste Sassi; John S K Kauwe; Steven Younkin; Lilinaz Hazrati; John Collinge; Jennifer Pocock; Tammaryn Lashley; Julie Williams; Jean-Charles Lambert; Philippe Amouyel; Alison Goate; Rosa Rademakers; Kevin Morgan; John Powell; Peter St George-Hyslop; Andrew Singleton; John Hardy
Journal:  N Engl J Med       Date:  2012-11-14       Impact factor: 91.245

8.  Mutation analysis of patients with neurodegenerative disorders using NeuroX array.

Authors:  Mahdi Ghani; Anthony E Lang; Lorne Zinman; Benedetta Nacmias; Sandro Sorbi; Valentina Bessi; Andrea Tedde; Maria Carmela Tartaglia; Ezequiel I Surace; Christine Sato; Danielle Moreno; Zhengrui Xi; Rachel Hung; Mike A Nalls; Andrew Singleton; Peter St George-Hyslop; Ekaterina Rogaeva
Journal:  Neurobiol Aging       Date:  2014-08-01       Impact factor: 4.673

9.  Missense variant in TREML2 protects against Alzheimer's disease.

Authors:  Bruno A Benitez; Sheng Chih Jin; Rita Guerreiro; Rob Graham; Jenny Lord; Denise Harold; Rebecca Sims; Jean-Charles Lambert; J Raphael Gibbs; Jose Bras; Celeste Sassi; Oscar Harari; Sarah Bertelsen; Michelle K Lupton; John Powell; Celine Bellenguez; Kristelle Brown; Christopher Medway; Patrick C G Haddick; Marcel P van der Brug; Tushar Bhangale; Ward Ortmann; Tim Behrens; Richard Mayeux; Margaret A Pericak-Vance; Lindsay A Farrer; Gerard D Schellenberg; Jonathan L Haines; Jim Turton; Anne Braae; Imelda Barber; Anne M Fagan; David M Holtzman; John C Morris; Julie Williams; John S K Kauwe; Philippe Amouyel; Kevin Morgan; Andy Singleton; John Hardy; Alison M Goate; Carlos Cruchaga
Journal:  Neurobiol Aging       Date:  2013-12-21       Impact factor: 4.673

10.  Genomic DNA Copy Number Aberrations, Histological Diagnosis, Oral Subsite and Aneuploidy in OPMDs/OSCCs.

Authors:  Patrizio Castagnola; Gabriele Zoppoli; Sergio Gandolfo; Massimiliano Monticone; Davide Malacarne; Gabriella Cirmena; David Brown; Cinzia Aiello; Massimo Maffei; Roberto Marino; Walter Giaretti; Monica Pentenero
Journal:  PLoS One       Date:  2015-11-05       Impact factor: 3.240

View more
  14 in total

Review 1.  Genetics of Alzheimer's Disease: the Importance of Polygenic and Epistatic Components.

Authors:  Neha Raghavan; Giuseppe Tosto
Journal:  Curr Neurol Neurosci Rep       Date:  2017-08-21       Impact factor: 5.081

2.  Protective Variants in Alzheimer's Disease.

Authors:  Shea J Andrews; Brian Fulton-Howard; Alison Goate
Journal:  Curr Genet Med Rep       Date:  2019-01-24

3.  Genetic Analysis of TREM2 Variants in Tunisian Patients with Alzheimer's Disease.

Authors:  Zied Landoulsi; Mouna Ben Djebara; Imen Kacem; Youssef Sidhom; Rym Kefi; Sonia Abdelhak; Amina Gargouri-Berrechid; Riadh Gouider
Journal:  Med Princ Pract       Date:  2018-05-03       Impact factor: 1.927

4.  Myeloid cell-like transcript 2 is related to liver inflammation and the pathogenesis of hepatitis B via the involvement of CD8+T cell activation.

Authors:  Jun-Chi Xu; Fei Gao; Yi-An Liu; Xiao-Long Zhang; Hui Chen; Xiao-Yan Zhu; Hua-Feng Song; Feng Qian; Ming Li; Chen Yang; Chuan-Wu Zhu; Ping Xu
Journal:  Clin Exp Med       Date:  2018-10-25       Impact factor: 3.984

Review 5.  Potential Bidirectional Relationship Between Periodontitis and Alzheimer's Disease.

Authors:  Daniela Liccardo; Federica Marzano; Federica Carraturo; Marco Guida; Grazia Daniela Femminella; Leonardo Bencivenga; Jacopo Agrimi; Armida Addonizio; Imma Melino; Alessandra Valletta; Carlo Rengo; Nicola Ferrara; Giuseppe Rengo; Alessandro Cannavo
Journal:  Front Physiol       Date:  2020-07-03       Impact factor: 4.566

6.  TREM2 brain transcript-specific studies in AD and TREM2 mutation carriers.

Authors:  Jorge L Del-Aguila; Bruno A Benitez; Zeran Li; Umber Dube; Kathie A Mihindukulasuriya; John P Budde; Fabiana H G Farias; Maria Victoria Fernández; Laura Ibanez; Shan Jiang; Richard J Perrin; Nigel J Cairns; John C Morris; Oscar Harari; Carlos Cruchaga
Journal:  Mol Neurodegener       Date:  2019-05-08       Impact factor: 14.195

Review 7.  New insights into the role of TREM2 in Alzheimer's disease.

Authors:  Maud Gratuze; Cheryl E G Leyns; David M Holtzman
Journal:  Mol Neurodegener       Date:  2018-12-20       Impact factor: 14.195

8.  TREM2 shedding by cleavage at the H157-S158 bond is accelerated for the Alzheimer's disease-associated H157Y variant.

Authors:  Peter Thornton; Jean Sevalle; Michael J Deery; Graham Fraser; Ye Zhou; Sara Ståhl; Elske H Franssen; Roger B Dodd; Seema Qamar; Beatriz Gomez Perez-Nievas; Louise Sc Nicol; Susanna Eketjäll; Jefferson Revell; Clare Jones; Andrew Billinton; Peter H St George-Hyslop; Iain Chessell; Damian C Crowther
Journal:  EMBO Mol Med       Date:  2017-10       Impact factor: 12.137

Review 9.  TREM2 in Neurodegenerative Diseases.

Authors:  Taylor R Jay; Victoria E von Saucken; Gary E Landreth
Journal:  Mol Neurodegener       Date:  2017-08-02       Impact factor: 14.195

10.  TREML4 Promotes Inflammatory Programs in Human and Murine Macrophages and Alters Atherosclerosis Lesion Composition in the Apolipoprotein E Deficient Mouse.

Authors:  Marieli Gonzalez-Cotto; Liang Guo; Megan Karwan; Shurjo K Sen; Jennifer Barb; Carlos J Collado; Fathi Elloumi; Erika M Palmieri; Kimberly Boelte; Frank D Kolodgie; Aloke V Finn; Leslie G Biesecker; Daniel W McVicar
Journal:  Front Immunol       Date:  2020-03-30       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.